Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BLOOM H. J. G. Prognosis in carcinoma of the breast. Br J Cancer. 1950 Sep;4(3):259–288. doi: 10.1038/bjc.1950.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bennett A., Charlier E. M., McDonald A. M., Simpson J. S., Stamford I. F., Zebro T. Prostaglandins and breast cancer. Lancet. 1977 Sep 24;2(8039):624–626. doi: 10.1016/s0140-6736(77)92496-5. [DOI] [PubMed] [Google Scholar]
- Currie G. A. Serum lysozyme as a marker of host resistance. II. Patients with malignant melanoma, hypernephroma or breast carcinoma. Br J Cancer. 1976 Jun;33(6):593–599. doi: 10.1038/bjc.1976.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cuschieri A., Jarvie R., Taylor W. H., Cant E., Furnival C. M., Blumgart L. H. Three-centre study on urinary hydroxyproline excretion in cancer of the breast. Br J Cancer. 1978 Jun;37(6):1002–1005. doi: 10.1038/bjc.1978.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cuschieri A. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study. Br J Surg. 1973 Oct;60(10):800–803. doi: 10.1002/bjs.1800601012. [DOI] [PubMed] [Google Scholar]
- Eccles S. A., Alexander P. Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature. 1974 Aug 23;250(5468):667–669. doi: 10.1038/250667a0. [DOI] [PubMed] [Google Scholar]
- Fisher B., Slack N. H. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet. 1970 Jul;131(1):79–88. [PubMed] [Google Scholar]
- Freshney R. I., Paul J., Kane I. M. Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer. 1975 Jan;31(1):89–99. doi: 10.1038/bjc.1975.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hendrick J. C., Franchimont P. Proceedings: Radioimmunoassay of casein in the serum of normal subjects and of patients with various malignancies. Br J Cancer. 1974 Aug;30(2):176–176. doi: 10.1038/bjc.1974.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim U. Metastasizing mammary carcinomas in rats: induction and study of their immunogenicity. Science. 1970 Jan 2;167(3914):72–74. doi: 10.1126/science.167.3914.72. [DOI] [PubMed] [Google Scholar]
- Maynard P. V., Blamey R. W., Elston C. W., Haybittle J. L., Griffiths K. Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res. 1978 Nov;38(11 Pt 2):4292–4295. [PubMed] [Google Scholar]
- Merrick M. V. Review article-Bone scanning. Br J Radiol. 1975 May;48(569):327–351. doi: 10.1259/0007-1285-48-569-327. [DOI] [PubMed] [Google Scholar]
- Roberts J. G., Keyser J. W., Baum M. Serum alpha-1-acid glycoprotein as an index of dissemination in breast cancer. Br J Surg. 1975 Oct;62(10):816–819. doi: 10.1002/bjs.1800621017. [DOI] [PubMed] [Google Scholar]
- Shousha S., Lyssiotis T., Godfrey V. M., Scheuer P. J. Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator. Br Med J. 1979 Mar 24;1(6166):777–779. doi: 10.1136/bmj.1.6166.777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Smith I. E., Taylor K. J., McCready V. R., Powles T. J., Bondy P. K. A comparision of grey-scale ultrasound with other methods for the detection of liver metastases from breast carcinoma. Clin Oncol. 1976 Mar;2(1):47–53. [PubMed] [Google Scholar]
- Tormey D. C., Waalkes T. P., Snyder J. J., Simon R. M. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen. Cancer. 1977 Jun;39(6):2397–2404. doi: 10.1002/1097-0142(197706)39:6<2397::aid-cncr2820390614>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
